SpringWorks rises on Q2 revenue beat

SpringWorks Therapeutics

07/08/2024 11:58

** Shares of SpringWorks Therapeutics  SWTX.O  rise 5.3% to
$34.97 premarket
    ** Drugmaker's Q2 rev of $59.7 mln beats Wall Street
estimates of $34.3 mln - LSEG
    ** Co's Q2 loss of 54 cents/shr is narrower than $1.25/shr a
year ago
    ** Up to last close, stock down 9% YTD

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))